Annual Current Liabilities
$64.51 M
-$8.08 M-11.13%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual total current liabilities is $64.51 million, with the most recent change of -$8.08 million (-11.13%) on December 31, 2023.
- During the last 3 years, VYGR annual current liabilities has risen by +$37.74 million (+141.01%).
- VYGR annual current liabilities is now -15.13% below its all-time high of $76.01 million, reached on December 31, 2019.
Performance
VYGR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$44.21 M
+$4.08 M+10.17%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly total current liabilities is $44.21 million, with the most recent change of +$4.08 million (+10.17%) on September 30, 2024.
- Over the past year, VYGR quarterly current liabilities has dropped by -$20.30 million (-31.47%).
- VYGR quarterly current liabilities is now -56.52% below its all-time high of $101.68 million, reached on March 31, 2022.
Performance
VYGR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VYGR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.1% | -31.5% |
| 3 y3 years | +141.0% | -39.1% |
| 5 y5 years | +103.7% | -39.1% |
VYGR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.1% | +26.5% | -56.5% | +121.7% |
| 5 y | 5-year | -15.1% | +141.0% | -56.5% | +121.7% |
| alltime | all time | -15.1% | +2507.4% | -56.5% | +1687.0% |
Voyager Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.21 M(+10.2%) |
| Jun 2024 | - | $40.13 M(-44.7%) |
| Mar 2024 | - | $72.55 M(+12.5%) |
| Dec 2023 | $64.51 M(-11.1%) | $64.51 M(+4.6%) |
| Sep 2023 | - | $61.69 M(+35.9%) |
| Jun 2023 | - | $45.40 M(+127.7%) |
| Mar 2023 | - | $19.94 M(-72.5%) |
| Dec 2022 | $72.59 M(+42.4%) | $72.59 M(-0.9%) |
| Sep 2022 | - | $73.24 M(-25.2%) |
| Jun 2022 | - | $97.93 M(-3.7%) |
| Mar 2022 | - | $101.68 M(+99.4%) |
| Dec 2021 | $50.98 M(+90.5%) | $50.98 M(+90.9%) |
| Sep 2021 | - | $26.70 M(+8.2%) |
| Jun 2021 | - | $24.69 M(-0.3%) |
| Mar 2021 | - | $24.75 M(-7.5%) |
| Dec 2020 | $26.77 M(-64.8%) | $26.77 M(-36.4%) |
| Sep 2020 | - | $42.05 M(-37.7%) |
| Jun 2020 | - | $67.53 M(-6.9%) |
| Mar 2020 | - | $72.54 M(-4.6%) |
| Dec 2019 | $76.01 M | $76.01 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $80.17 M(+15.9%) |
| Jun 2019 | - | $69.15 M(+17.6%) |
| Mar 2019 | - | $58.78 M(+85.6%) |
| Dec 2018 | $31.67 M(+99.2%) | $31.67 M(+5.5%) |
| Sep 2018 | - | $30.03 M(+3.2%) |
| Jun 2018 | - | $29.09 M(-6.0%) |
| Mar 2018 | - | $30.94 M(+94.6%) |
| Dec 2017 | $15.90 M(+15.2%) | $15.90 M(-24.1%) |
| Sep 2017 | - | $20.94 M(+76.9%) |
| Jun 2017 | - | $11.84 M(+7.0%) |
| Mar 2017 | - | $11.06 M(-19.8%) |
| Dec 2016 | $13.80 M(-42.3%) | $13.80 M(-28.8%) |
| Sep 2016 | - | $19.39 M(-1.9%) |
| Jun 2016 | - | $19.76 M(-14.4%) |
| Mar 2016 | - | $23.08 M(-3.6%) |
| Dec 2015 | $23.93 M(+867.3%) | $23.93 M(+2.4%) |
| Sep 2015 | - | $23.37 M(+2.5%) |
| Jun 2015 | - | $22.79 M(+821.2%) |
| Dec 2014 | $2.47 M(-37.9%) | $2.47 M |
| Dec 2013 | $3.98 M | - |
FAQ
- What is Voyager Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Voyager Therapeutics?
- What is Voyager Therapeutics annual current liabilities year-on-year change?
- What is Voyager Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly current liabilities year-on-year change?
What is Voyager Therapeutics annual total current liabilities?
The current annual current liabilities of VYGR is $64.51 M
What is the all time high annual current liabilities for Voyager Therapeutics?
Voyager Therapeutics all-time high annual total current liabilities is $76.01 M
What is Voyager Therapeutics annual current liabilities year-on-year change?
Over the past year, VYGR annual total current liabilities has changed by -$8.08 M (-11.13%)
What is Voyager Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VYGR is $44.21 M
What is the all time high quarterly current liabilities for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly total current liabilities is $101.68 M
What is Voyager Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VYGR quarterly total current liabilities has changed by -$20.30 M (-31.47%)